ClinicalTrials.Veeva

Menu

Critical Respiratory Events in Children Requiring Naloxone: Naloxone Use as Opioid Safety Measure

Cincinnati Children's Hospital Medical Center logo

Cincinnati Children's Hospital Medical Center

Status

Completed

Conditions

Opioid Induced Respiratory Depression

Study type

Observational

Funder types

Other

Identifiers

NCT01860885
CIN1-2012-1219

Details and patient eligibility

About

Opioids are the mainstay of analgesia in hospitalized children but opioid therapy is associated with life-threatening respiratory depression requiring antagonism with naloxone. Hence, it is hypothesized that naloxone requirement can be used as a quality measure of opioid safety. A retrospective medical chart review of 95 patients, who received naloxone for life threatening events, from June 2006-2012, is planned, to identify significant factors associated with risk for opioid induced respiratory depression and formulation of preventive strategies.

Enrollment

95 patients

Sex

All

Ages

1+ day old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • any gender, age or race
  • administered naloxone for opioid induced respiratory depression

Exclusion criteria

  • Any one who did not require naloxone for opioid induced respiratory depression

Trial design

95 participants in 1 patient group

Patients requiring naloxone for respiratory depression

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems